Skip to Content

Quantrx Biomedical Corp QTXB

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

QTXB is trading at a 778% premium.
Price
$0.00
Fair Value
$3.53
Uncertainty
Extreme
1-Star Price
$6.87
5-Star Price
$9.96
Economic Moat
Chfd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QTXB is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.00
Market Cap
$314,785.84
Volume/Avg
50,000 / 29,750

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Quantrx Biomedical Corp operates towards the development and commercialization of patented mini form pad (PAD) based products. The PAD products are based on the company's non-woven disposable absorbent pad technology and it is involved in the PAD-based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its platforms include inSync(R), Unique(TM), and OEM branded over-the-counter and laboratory testing products.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
Website

Valuation

Metric
QTXB
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
QTXB

Financial Strength

Metric
QTXB
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
−0.21
Quick Ratio
QTXB

Profitability

Metric
QTXB
Return on Assets (Normalized)
−3,032.82%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
QTXB
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
HydvxbwcbYdgd$151.2 Bil
Becton Dickinson & Co
BDX
WtdvdvgpdKcpcl$67.6 Bil
Alcon Inc
ALC
YnspgxhKldvd$44.2 Bil
ResMed Inc
RMD
RbrtgxqbKldjkc$30.3 Bil
Coloplast A/S ADR
CLPBY
DsxnvynvBykhc$28.4 Bil
West Pharmaceutical Services Inc
WST
XmxfldkvKgng$23.9 Bil
Hologic Inc
HOLX
XhldgrbhBlzqjnd$18.4 Bil
Baxter International Inc
BAX
FmkgcdbfYvdfxm$18.2 Bil
The Cooper Companies Inc
COO
KldntyjkgGpvzv$18.1 Bil
Teleflex Inc
TFX
ZxqfsBwt$10.8 Bil

Sponsor Center